Bijean Ford

Bijean Ford, Ph.D., is a seasoned Senior Medical Writer currently employed at MMS since April 2024. Previously, Bijean served as Senior Manager of Medical Writing following the acquisition of Intercept Pharmaceuticals by AlfaSigma Global. Bijean's extensive experience includes significant roles at Intercept Pharmaceuticals as Senior Manager of Regulatory Medical Writing, where Bijean authored regulatory documents adherent to FDA standards. Additionally, Bijean contributed as a Mentor and Instructor at The Biotechnology Institute, a Freelance Medical Writer for Lupus Research Alliance, and held various scientific roles during academic training at Emory University, culminating in a Ph.D. in Immunology and Pathogenesis. Bijean possesses a strong background in medical writing, regulatory submissions, and scientific communication.